Skip to main content

August 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology

FDA Approvals
The WEE1 Inhibitor Adavosertib Displays Promising Clinical Activity in Uterine Serous Cancer
Wayne Kuznar
Read More
FDA Approvals
Intratumoral Injection of Cisplatin and Vinblastine, with or without Pembrolizumab, Improves Intracellular Transport in Patients with Advanced Solid Tumors
Chase Doyle
Read More
Adjuvant Atezolizumab Did Not Show Disease-Free Survival Benefit in High-Risk Urothelial Cancer
Phoebe Starr
Read More
Prostate Cancer
Early Phase 2 Data Promising for Lutetium-177 PSMA-617 in Metastatic Prostate Cancer
Phoebe Starr
Read More
Leukemia, Lymphoma, Oncology
Axicabtagene Ciloleucel Induces Durable Responses in Advanced Follicular and Marginal-Zone Lymphoma
Wayne Kuznar
Read More
Leukemia, Lymphoma, Oncology
CAR T-Cell Therapy Shows Highly Durable Remissions in CLL and B-Cell Lymphoma
Chase Doyle
Read More
Page 3 of 3
Results 21 - 26 of 26